SPRO - Spero Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SPRO is currently covered by 4 analysts with an average price target of $8.72. This is a potential upside of $7.81 (858.24%) from yesterday's end of day stock price of $0.91.

Spero Therapeutics's activity chart (see below) currently has 18 price targets and 33 ratings on display. The stock rating distribution of SPRO is 94.12% BUY and 5.88% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.22% with an average time for these price targets to be met of 40.5 days.

Highest price target for SPRO is $5, Lowest price target is $5, average price target is $8.72.

Most recent stock forecast was given by JOSH SCHIMMER from EVERCORE on 20-Dec-2024.

Best performing analysts who are covering SPRO - Spero Therapeutics:

Kevin Degeeter Esther Hong Raghuram Selvaraju Louise Chen Josh Schimmer Ritu Baral

Currently out of the existing stock ratings of SPRO, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$5

$3.9 (354.55%)

$8

29 days ago
(20-Dec-2024)

1/3 (33.33%)

$4 (400.00%)

2

Buy

$5

$3.9 (354.55%)

$5

1 months 16 days ago
(02-Dec-2024)

0/17 (0%)

$3.87 (342.48%)

Buy

2 months 3 days ago
(15-Nov-2024)

0/3 (0%)

$3.35 (203.03%)

Hold

$47

2 years 7 months 29 days ago
(20-May-2022)

0/1 (0%)

$28.64 (155.99%)

Buy

$21

3 years 3 months 17 days ago
(01-Oct-2021)

2/2 (100%)

$7.02 (60.23%)

241

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SPRO (Spero Therapeutics) average time for price targets to be met?

On average it took 40.5 days on average for the stock forecasts to be realized with a an average price target met ratio 22.22

Which analyst has the current highest performing score on SPRO (Spero Therapeutics) with a proven track record?

KEVIN DEGEETER

Which analyst has the current lower performing score on SPRO (Spero Therapeutics) with a proven track record?

RITU BARAL

Which analyst has the most public recommendations on SPRO (Spero Therapeutics)?

Kevin Degeeter has 7 price targets and 6 ratings on SPRO

Which analyst is the currently most bullish on SPRO (Spero Therapeutics)?

Josh Schimmer with highest potential upside - $3.9

Which analyst is the currently most reserved on SPRO (Spero Therapeutics)?

Esther Hong with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?